華廣生技股份有限公司
華廣生技股份有限公司（Bionime Corporation）設計、製造與銷售醫療儀器。主要製造血糖監測儀與測試片，提供給醫材公司、藥局及醫院。以「RIGHTEST」品牌行銷血糖管理系統，並開發連續血糖監測系統（CGM）。此外涉及精準儀器銷售。公司成立於 2003 年，總部位於台灣台中。
今日上漲 1.44%，股價站回短期均線。該股 RSI(6) 為 60.5，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、20日均線，跌破60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=34.2）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-11 | +36 | 0 | 0 | +36 |
| 08-10 | +27 | 0 | 0 | +27 |
| 08-07 | +19 | 0 | 0 | +19 |
| 08-06 | -25 | 0 | -1 | -26 |
| 08-05 | +13 | 0 | 0 | +13 |
| 08-04 | +2 | 0 | -5 | -3 |
| 08-03 | -35 | 0 | -1 | -36 |
| 07-31 | -22 | 0 | 0 | -22 |
| 07-30 | +13 | 0 | -13 | 0 |
| 07-29 | +84 | 0 | +1 | +85 |
| 07-28 | +27 | 0 | +15 | +42 |
| 07-27 | +4 | 0 | 0 | +4 |
| 07-24 | +5 | 0 | 0 | +5 |
| 07-23 | -13 | 0 | 0 | -13 |
| 07-22 | -9 | 0 | -7 | -16 |
| 07-21 | -24 | 0 | -5 | -29 |
| 07-20 | -7 | 0 | +3 | -4 |
| 07-17 | +2 | 0 | -5 | -3 |
| 07-16 | -52 | 0 | -18 | -70 |
| 07-15 | -67 | 0 | -7 | -74 |
| 07-14 | +2 | 0 | -21 | -18 |
| 07-13 | -7 | 0 | +21 | +14 |
| 07-09 | +23 | 0 | -1 | +22 |
| 07-08 | +8 | 0 | -1 | +7 |
| 07-07 | +3 | 0 | +2 | +5 |
| 07-06 | -31 | 0 | 0 | -31 |
| 07-03 | +51 | 0 | 0 | +51 |
| 07-02 | +8 | 0 | 0 | +8 |
| 07-01 | +45 | 0 | 0 | +45 |
| 06-30 | -25 | 0 | 0 | -25 |
| 06-29 | +14 | 0 | 0 | +14 |
| 06-26 | -57 | 0 | -2 | -59 |
| 06-25 | -26 | 0 | +1 | -25 |
| 06-24 | +78 | 0 | -1 | +77 |
| 06-22 | -1 | 0 | 0 | -1 |
| 06-18 | -15 | 0 | 0 | -15 |
| 06-17 | -12 | 0 | +1 | -11 |
| 06-16 | -20 | 0 | -1 | -21 |
| 06-15 | -21 | 0 | +2 | -19 |
| 06-12 | -26 | 0 | 0 | -26 |
| 06-10 | -9 | 0 | -1 | -10 |
| 06-09 | -7 | 0 | 0 | -7 |
| 06-08 | -38 | 0 | +1 | -37 |
| 06-04 | +8 | 0 | +2 | +10 |
| 06-03 | -21 | 0 | -2 | -23 |
| 06-02 | -7 | 0 | -1 | -8 |
| 06-01 | +10 | 0 | -1 | +9 |
| 05-29 | +5 | 0 | 0 | +5 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/06 | 1.44 億 | +1.4% | -6.5% |
| 2026/05 | 1.42 億 | +0.3% | -13.4% |
| 2026/04 | 1.41 億 | -15.6% | -8.4% |
| 2026/03 | 1.67 億 | +51.5% | +4.7% |
| 2026/02 | 1.11 億 | -13.1% | -28.9% |
| 2026/01 | 1.27 億 | -20.9% | -23.3% |
| 2025/12 | 1.61 億 | +25.0% | +12.8% |
| 2025/11 | 1.29 億 | -6.3% | -29.1% |
| 2025/10 | 1.37 億 | -7.8% | -22.8% |
| 2025/09 | 1.49 億 | -10.9% | -8.1% |
| 2025/08 | 1.67 億 | +17.5% | +0.2% |
| 2025/07 | 1.42 億 | - | -10.6% |